Wolters Kluwer, American Association for the Study of Liver Diseases announce publishing collaboration

Wolters Kluwer, Health, a leading global provider of information and point of care solutions for the healthcare industry, and American Association for the Study of Liver Diseases (AASLD), the leading organization of physicians, scientists, and other health care professionals committed to preventing and curing liver disease, have entered into a multi-year agreement.

Under this agreement, beginning in January 2023, Wolters Kluwer will publish AASLD’s portfolio of four specialty journals, including its premier publication HEPATOLOGY, which features peer-reviewed articles on all aspects of liver structure, function, and disease, selected by their distinguished editorial board.

Wolters Kluwer will focus on expanding AASLD’s journal readership globally through access and distribution on the Ovid® medical research platform, among other channels, as well as the potential to reach members and practitioners through new digital channels.

“This is an exciting day for AASLD,” said AASLD President Dr. Laurie D. DeLeve, MD, PhD, FAASLD. “AASLD prides itself on advancing cutting-edge research that progresses the field of hepatology in preventing, diagnosing, and treating diseases. Wolters Kluwer brings extensive knowledge on the future of medical publishing to the partnership and their strategic guidance will allow us to push those discoveries to even greater heights.”

“We believe that Wolters Kluwer is the right partner to support AASLD’s family of journals as we strive to expand and improve services to authors and readers in all four of our journals,” said AASLD Chief Executive Officer Matthew D’Uva, FASAE, CAE. “We are excited by Wolters Kluwer’s expertise in medical publishing and their capacity to help us expand our reach to new audiences and offer new benefits to our members.”

“We are honored to work with the American Association for the Study of Liver Diseases to grow and expand the reach of their prominent portfolio of hepatology publications,” said Jennifer Brogan, Vice President, Global Journal Publishing and Society Solutions at Wolters Kluwer. “In their commitment to prevent and cure liver disease, AASLD is continually innovating to keep pace with both research and practice advancements. Partnering with AASLD’s team, we can ensure that practitioners everywhere are equipped with the latest evidence-based research to improve care and outcomes for patients with liver disease.”

AASLD’s journal publications include:

• HEPATOLOGY - Publishes original, peer-reviewed articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism.
• Liver Transplantation - Delivers current content on liver transplantation, liver surgery, and chronic liver disease.
• Clinical Liver Disease - Provides education for clinicians diagnosing and managing patients with liver disease through articles that are accompanied by visual abstracts, podcasts, author videos, and/or slide sets. Readers can earn Continuing Medical Education (CME) credits through its content.
• Hepatology Communications - Offers peer-reviewed, online-only, open access hepatology basic, clinical, and translational research.

To learn more about the American Association for the Study of Liver Diseases, please visit www.aasld.org. 

AASLD and Wolters Kluwer are exhibiting at Digestive Disease Week (DDW) 2022 in San Diego, CA, May 21-24, 2022.